We’re thrilled to announce that these talented & accomplished women are joining #TeamAscidian to help lead our development team!👏

Learn more about them & how they’ll help advance revolutionary #ExonEditing therapies for patients awaiting breakthroughs.👇
https://www.linkedin.com/posts/ascidian-therapeutics_exonediting-rewritingrna-teamascidian-activity-7051513756354256896-A75E?utm_source=share&utm_medium=member_desktop

https://ascidian-tx.com/press-releases/

We’re thrilled to announce that these talented & accomplished women are joining #TeamAscidian to help lead our development team!👏

Learn more about them & how they’ll help advance revolutionary #ExonEditing therapies for patients awaiting breakthroughs.👇
https://ascidian-tx.com/press-releases/

https://www.linkedin.com/posts/ascidian-therapeutics_exonediting-rewritingrna-teamascidian-activity-7051513756354256896-A75E?utm_source=share&utm_medium=member_desktop

We’re thrilled to welcome Jay Barth, MD to Ascidian as Chief Medical Officer! 👏

Jay’s expertise in gene therapy and complex indications will make an immense impact for patients and for Ascidian as we advance our #ExonEditing therapies addressing underlying causes of disease.

Meet Jay and hear why he’s excited to join Ascidian! 👇

Learn more here: https://ascidian-tx.com/wp-content/uploads/2023/03/Ascidian-Therapeutics_Jay-Barth-Appointment_FINAL-final_20-March-2023.pdf

🗣️📢 It’s Ascidian’s podcast debut! Listen to our CEO Romesh Subramanian discuss our unique #ExonEditing approach (#RewritingRNA), the inspiration behind our name, and his pick on where to grab lunch in Boston.

Check out the Cell & Gene podcast with Erin Harris here!👇
http://bit.ly/400PMSq

In this #NatureBiotechnology article by Cormac Sheridan, we highlight the possibilities of RNA editing and what makes Ascidian's #ExonEditing approach unique.

👉Shoot the messenger: RNA editing is here👇
https://www.nature.com/articles/s41587-023-01709-8